- Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 | NEJM nejm.org
- COVID-19 drug therapy is available to help immunocompromised patients KSDK News
- Monoclonal-antibody combination AZD7442 prevents COVID-19 News-Medical.Net
- View Full Coverage on Google News